A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using...

Por Julka, P K, Chacko, R T, Nag, S, Parshad, R, Nair, A, Oh, D S, Hu, Z, Koppiker, C B, Nair, S, Dawar, R, Dhindsa, N, Miller, I D, Ma, D, Lin, B, Awasthy, B, Perou, C M
Publicado em 2008